Morgan Stanley’s Bolt Biotherapeutics BOLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.7K | Buy |
3,579
+2,998
| +516% | +$17.3K | ﹤0.01% | 6642 |
|
|
2025
Q1 | $4.65K | Hold |
581
| – | – | ﹤0.01% | 7009 |
|
|
2024
Q4 | $6.22K | Sell |
581
-591
| -50% | -$6.32K | ﹤0.01% | 6946 |
|
|
2024
Q3 | $15.2K | Sell |
1,172
-512
| -30% | -$6.64K | ﹤0.01% | 6592 |
|
|
2024
Q2 | $25.3K | Buy |
1,684
+450
| +36% | +$6.75K | ﹤0.01% | 6379 |
|
|
2024
Q1 | $34.6K | Sell |
1,234
-6,705
| -84% | -$188K | ﹤0.01% | 6344 |
|
|
2023
Q4 | $178K | Sell |
7,939
-49
| -0.6% | -$1.1K | ﹤0.01% | 5988 |
|
|
2023
Q3 | $166K | Buy |
7,988
+6,310
| +376% | +$131K | ﹤0.01% | 5666 |
|
|
2023
Q2 | $43K | Sell |
1,678
-13,642
| -89% | -$349K | ﹤0.01% | 6268 |
|
|
2023
Q1 | $426K | Buy |
15,320
+13,576
| +778% | +$377K | ﹤0.01% | 5345 |
|
|
2022
Q4 | $45.3K | Sell |
1,744
-1,808
| -51% | -$47K | ﹤0.01% | 6338 |
|
|
2022
Q3 | $105K | Sell |
3,552
-16,992
| -83% | -$502K | ﹤0.01% | 6051 |
|
|
2022
Q2 | $838K | Sell |
20,544
-646
| -3% | -$26.4K | ﹤0.01% | 5124 |
|
|
2022
Q1 | $1.16M | Sell |
21,190
-1,365
| -6% | -$74.8K | ﹤0.01% | 4886 |
|
|
2021
Q4 | $2.21M | Buy |
22,555
+13,441
| +147% | +$1.32M | ﹤0.01% | 4507 |
|
|
2021
Q3 | $2.31M | Sell |
9,114
-4,703
| -34% | -$1.19M | ﹤0.01% | 4454 |
|
|
2021
Q2 | $4.27M | Buy |
13,817
+13,580
| +5,730% | +$4.2M | ﹤0.01% | 3944 |
|
|
2021
Q1 | $156K | Buy |
+237
| New | +$156K | ﹤0.01% | 5797 |
|